KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Assets (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Return on Assets for 12 consecutive years, with 0.36% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 16.0% to 0.36% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.36% through Dec 2025, up 16.0% year-over-year, with the annual reading at 0.3% for FY2025, 20.0% up from the prior year.
  • Return on Assets hit 0.36% in Q4 2025 for Arbutus Biopharma, up from 0.42% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.31% in Q2 2022 to a low of 0.62% in Q1 2025.
  • Historically, Return on Assets has averaged 0.44% across 5 years, with a median of 0.46% in 2021.
  • Biggest five-year swings in Return on Assets: skyrocketed 92bps in 2021 and later dropped -14bps in 2024.
  • Year by year, Return on Assets stood at 0.41% in 2021, then increased by 16bps to 0.35% in 2022, then plummeted by -38bps to 0.48% in 2023, then fell by -7bps to 0.51% in 2024, then surged by 31bps to 0.36% in 2025.
  • Business Quant data shows Return on Assets for ABUS at 0.36% in Q4 2025, 0.42% in Q3 2025, and 0.49% in Q2 2025.